At 24 weeks, the mean percentage decrease in weight ranged from 7.2% to 17.5% across retatrutide groups versus 1.6% with placebo
Semaglutide works by: Enhancing insulin secretion in a glucose-dependent manner, which helps regulate blood sugar levels Suppressing glucagon release , reducing hepatic glucose output Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake These combined effects led to significant weight loss in clinical trials (STEP programme), typically in the range of 1015% of body weight over 68 weeks, though individual results vary considerably
The oral form is formulated at a higher dose than the injectable version to account for what is lost during digestion and to ensure the medication is fully absorbed at therapeutic levels
If you want a grounded overview of currently used medicines in this area, Trim's guide to GLP-1 medicines in UK clinical practice is a useful starting point
Strength Training Is Key Make strength training a part of your weekly routine